Heron Therapeutics, Inc. (HRTX) News
Filter HRTX News Items
HRTX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HRTX News Highlights
- For HRTX, its 30 day story count is now at 7.
- Over the past 12 days, the trend for HRTX's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- NOTE are the most mentioned tickers in articles about HRTX.
Latest HRTX News From Around the Web
Below are the latest news stories about HERON THERAPEUTICS INC that investors may wish to consider to help them evaluate HRTX as an investment opportunity.
CEO & Director of Heron Therapeutics Craig Collard Buys 411% More SharesInvestors who take an interest in Heron Therapeutics, Inc. ( NASDAQ:HRTX ) should definitely note that the CEO... |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayIt's time to dive into the biggest pre-market stock movers as we check out all of the hottest news worth reading about on Wednesday! |
Heron Therapeutics Inc (HRTX) Raises 2023 Sales Guidance and Projects Positive EBITDA in 2024Strategic Cost Reductions and Product Sales Growth Propel Optimism for Profitability |
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2023 Earnings Call TranscriptHeron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2023 Earnings Call Transcript November 14, 2023 Heron Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.31. Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q3 2023 Earnings Conference Call. As a reminder, this conference is being recorded. […] |
Q3 2023 Heron Therapeutics Inc Earnings CallQ3 2023 Heron Therapeutics Inc Earnings Call |
Heron Therapeutics (HRTX) Q3 Earnings: How Key Metrics Compare to Wall Street EstimatesAlthough the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |
Heron Therapeutics Announces Third Quarter 2023 Financial Results and Updates Financial GuidanceHeron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care, today announced financial results for the three and nine months ended September 30, 2023 and highlighted recent corporate updates. |
Heron Therapeutics to Report Third Quarter 2023 Financial Results On Tuesday, November 14, 2023Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care, today announced that the company will host a conference call and live webcast on Tuesday, November 14, 2023 at 4:30 p.m. ET to report third quarter 2023 financial results and discuss recent business highlights. |
11 Best Long-Term Penny Stocks to Buy NowIn this article, we will take a look at the 11 best long-term penny stocks to buy now. To see more such companies, go directly to 5 Best Long-Term Penny Stocks to Buy Now. The Federal Reserve’s historic battle against inflation that started in 2022 has highlighted the importance of an already-known fact: if you […] |
Heron Therapeutics (HRTX) Reports Q2 Earnings: What Key Metrics Have to SayAlthough the revenue and EPS for Heron Therapeutics (HRTX) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. |